EpiEndo Pharmaceuticals Revenue and Competitors

Location

Total Funding

Industry

Estimated Revenue & Valuation

EpiEndo Pharmaceuticals's estimated annual revenue is currently $3.8M per year.(i)
EpiEndo Pharmaceuticals's estimated revenue per employee is $201,000

Name	Title	Email/Phone

Competitor Name	Revenue	Number of Employees	Employee Growth	Total Funding	Valuation
#1 Imaging Endpoin...	$46.2M	230	5%	N/A	N/A
#2 Southern Script...	$43.8M	218	21%	N/A	N/A
#3 Alfasigma USA	$57.1M	284	26%	N/A	N/A
#4 US WorldMeds	$24.5M	122	3%	N/A	N/A
#5 KCAS Bioanalyti...	$52.9M	263	13%	N/A	N/A
#6 BioTek reMEDys	$24.7M	123	13%	N/A	N/A
#7 Endocyte	$1.8M	18	0%	$114.3M	N/A
#8 Envision Commun...	$7.2M	36	-20%	N/A	N/A
#9 Peachtree Biore...	$13.7M	68	-7%	N/A	N/A
#10 Clearside BioMe...	$7.6M	39	-13%	$123.9M	N/A

EpiEndo Pharmaceuticals is an Icelandic pharmaceutical company focused on Chronic Airway Diseases. EpiEndo was founded in 2014.

keywords:N/A

N/A

Total Funding

Number of Employees

$3.8M

Revenue (est)

N/A

Employee Growth %

N/A

Valuation

N/A

Accelerator

At the Swedish American Life Sciences Summit, he was on a panel that awarded EpiEndo Pharmaceuticals the Rising Star Award.

Epiendo Pharmaceuticals ehf, of Reykjavik, Iceland, appointed Stefan Petursson chief financial officer, effective April 1.

EpiEndo Pharmaceuticals Expands its Leadership Team, Appointing Stefan Petursson as Chief Financial Officer to Support Future Growth.

Company Name	Revenue	Number of Employees	Employee Growth	Total Funding
#1 TripCreator	$2.4M	24	N/A	N/A
#2 Marport	$4.8M	28	-12%	N/A
#3 Guide to Icelan...	$6.1M	30	20%	N/A
#4 Citizens Founda...	$8.3M	32	N/A	N/A
#5 Travelshift	$6.9M	34	N/A	N/A